[1]
Boursiquot, J.-N. and Chapdelaine, H. 2025. Real-world Experience with Advanced Long-term Prophylaxis Agents to Treat Hereditary Angioedema in Canada. Canadian Allergy & Immunology Today. 5, s01 (Mar. 2025), 2–9. DOI:https://doi.org/10.58931/cait.2025.5s0176.